HBOT News & Research
Hyperbaric Oxygen Therapy (HBOT) is increasingly appearing in the news and new research as a treatment for a variety of conditions involving inflammation. Use the search or select an article below to keep up to date on the most recent HBOT News.
Recent Hyperbaric Oxygen Therapy (HBOT) News
Interpretation of subjective measures in a clinical trial of hyperbaric oxygen therapy for multiple sclerosis.
Abstract: Inclusion of subjective measures in clinical trials has raised questions concerning the basis on which their results may be compared with medical findings. Central problems relate to the status of such measures as indicators of 'real'...
Preliminary reports on hyperbaric oxygen therapy in multiple sclerosis.
Abstract: Preliminary clinical examinations comprised 16 patients suffering from multiple sclerosis, the mean duration of the disease 9.33 years, of the manifestations at different stages of the development--evaluated on the basis of Kurtzke scale....
[Hyperbaric oxygenation in the treatment of patients with ischemic stroke].
Abstract: Biochemical parameters (the gaseous composition and acid-base balance of the blood and cerebrospinal fluid (CSF) were investigated in patients with ischemic stroke in the process of hyperbaric oxygenation treatment. A characteristic...
Mechanisms of hyperbaric bradycardia.
Abstract: Relative bradycardias have been reported to occur in humans both at rest and during exercise under a variety of hyperbaric conditions. Review of existing data reveals that there are two major mechanisms operating: one depends on hyperoxia...
Smoke inhalation injury.
Abstract: , , , , , , , , (1988). Smoke inhalation injury. Postgraduate medicine, 1988 Jan;83(1):47,50. https://www.ncbi.nlm.nih.gov/pubmed/3336614
Evoked potentials to test a treatment of chronic multiple sclerosis.
Abstract: Multimodal evoked potentials (EPs) were obtained serially in 57 patients with multiple sclerosis enrolled in a double-blind, controlled study of hyperbaric oxygen. We encountered drawbacks in the use of EPs in monitoring effects of a...
A case of delayed-onset pulmonary barotrauma in a scuba diver.
Abstract: A 23-yr-old male scuba diver was admitted to the hyperbaric chamber of the Polish Army Training Centre of Divers and SCUBA Divers for treatment of pneumomediastinum and possible decompression sickness. Medical history suggested a case of...
Effect of anemia on tumor radiosensitivity under normo and hyperbaric conditions.
Abstract: The effect of chronic anemia on tumor radiosensitivity in a murine tumor has been investigated. Anemia was induced by bilateral kidney irradiation given several months before tumor implantation. Anemic, anemic transfused, and normal...
Hyperbaric oxygen and multiple sclerosis: final results of a placebo-controlled, double-blind trial.
The long term results are reported of a trial involving 120 patients with chronic multiple sclerosis who were randomised to receive either 100% oxygen at 2 atmospheres absolute (ATA) for 90 minutes daily for 20 sessions or placebo therapy with air using a simulated compression procedure. The previous finding of subjective improvement in bowel/bladder function at the end of treatment was not confirmed by objective urodynamic assessment. The treatment did not alter disease progression as measured by the Kurtzke disability status scale nor did it alter the rate of acute relapse. There was less deterioration in cerebellar function at one year in the treated patients as measured by the Kurtzke functional systems scale. No other differences were found between the two groups. Psychometric tests and measurements of lymphocyte sub-populations showed no treatment related effects. Evoked potential studies showed no improvements but there was a significant reduction in amplitude of the visual evoked potential in the treated patients at the end of therapy. This might indicate a reversible degree of retinal damage induced by oxygen toxicity.